Literature DB >> 9499092

Distinct pathways for tumor necrosis factor alpha and ceramides in human cytomegalovirus infection.

J Allan-Yorke1, M Record, C de Préval, C Davrinche, J L Davignon.   

Abstract

Human cytomegalovirus (HCMV) infection can be fatal to immunocompromised individuals. We have previously reported that gamma interferon and tumor necrosis factor alpha (TNF-alpha) synergistically inhibit HCMV replication in vitro. Ceramides have been described as second messengers induced by TNF-alpha. To investigate the mechanisms involved in the inhibition of HCMV by TNF-alpha, in the present study we have analyzed ceramide production by U373 MG astrocytoma cells and the effects of TNF-alpha versus ceramides on HCMV replication. Our results show that U373 MG cells did not produce ceramides upon incubation with TNF-alpha. Moreover, long-chain ceramides induced by treatment with exogenous bacterial sphingomyelinase inhibited HCMV replication in synergy with TNF-alpha. Surprisingly, short-chain permeant C6-ceramide increased viral replication. Our results show that the anti-HCMV activity of TNF-alpha is independent of ceramides. In addition, our results suggest that TNF-alpha and endogenous long-chain ceramides use separate pathways of cell signalling to inhibit HCMV replication, while permeant C6-ceramide appears to activate a third pathway leading to an opposite effect.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9499092      PMCID: PMC109531          DOI: 10.1128/JVI.72.3.2316-2322.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

Review 1.  Mitogen-activated protein kinase pathways.

Authors:  M J Robinson; M H Cobb
Journal:  Curr Opin Cell Biol       Date:  1997-04       Impact factor: 8.382

2.  Antiviral effects of recombinant tumour necrosis factor in vitro.

Authors:  J Mestan; W Digel; S Mittnacht; H Hillen; D Blohm; A Möller; H Jacobsen; H Kirchner
Journal:  Nature       Date:  1986 Oct 30-Nov 5       Impact factor: 49.962

3.  Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1.

Authors:  W A Bresnahan; I Boldogh; E A Thompson; T Albrecht
Journal:  Virology       Date:  1996-10-01       Impact factor: 3.616

4.  Human cytomegalovirus infection inhibits cell cycle progression at multiple points, including the transition from G1 to S.

Authors:  M Lu; T Shenk
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

5.  Signal transduction by tumor necrosis factor mediated by JNK protein kinases.

Authors:  H K Sluss; T Barrett; B Dérijard; R J Davis
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

6.  Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest.

Authors:  F M Jault; J M Jault; F Ruchti; E A Fortunato; C Clark; J Corbeil; D D Richman; D H Spector
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation.

Authors:  M Y Kim; C Linardic; L Obeid; Y Hannun
Journal:  J Biol Chem       Date:  1991-01-05       Impact factor: 5.157

8.  Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway.

Authors:  W D Jarvis; R N Kolesnick; F A Fornari; R S Traylor; D A Gewirtz; S Grant
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

9.  Role of ceramide in mitogenesis induced by exogenous sphingoid bases.

Authors:  J M Hauser; B M Buehrer; R M Bell
Journal:  J Biol Chem       Date:  1994-03-04       Impact factor: 5.157

10.  CD28 signals through acidic sphingomyelinase.

Authors:  L M Boucher; K Wiegmann; A Fütterer; K Pfeffer; T Machleidt; S Schütze; T W Mak; M Krönke
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

View more
  8 in total

1.  The IκB Kinases Restrict Human Cytomegalovirus Infection.

Authors:  Christopher M Goodwin; Joshua Munger
Journal:  J Virol       Date:  2019-04-17       Impact factor: 5.103

2.  Activation of the mitogen-activated protein kinase p38 by human cytomegalovirus infection through two distinct pathways: a novel mechanism for activation of p38.

Authors:  R A Johnson; S M Huong; E S Huang
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  The human cytomegalovirus UL26 protein antagonizes NF-κB activation.

Authors:  Chun Mathers; Xenia Schafer; Luis Martínez-Sobrido; Joshua Munger
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

Review 4.  Signal transduction of stress via ceramide.

Authors:  S Mathias; L A Peña; R N Kolesnick
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

5.  Maintenance of cytomegalovirus-specific CD4pos T-cell response in rheumatoid arthritis patients receiving anti-tumor necrosis factor treatments.

Authors:  Jean-Luc Davignon; Jean-Frédéric Boyer; Bénédicte Jamard; Delphine Nigon; Arnaud Constantin; Alain Cantagrel
Journal:  Arthritis Res Ther       Date:  2010-07-15       Impact factor: 5.156

6.  Human cytomegalovirus regulates bioactive sphingolipids.

Authors:  Nicholas J Machesky; Guojuan Zhang; Bindu Raghavan; Pete Zimmerman; Samuel L Kelly; Alfred H Merrill; W James Waldman; James R Van Brocklyn; Joanne Trgovcich
Journal:  J Biol Chem       Date:  2008-07-20       Impact factor: 5.157

7.  Human cytomegalovirus infection inhibits tumor necrosis factor alpha (TNF-alpha) signaling by targeting the 55-kilodalton TNF-alpha receptor.

Authors:  J Baillie; D A Sahlender; J H Sinclair
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

Review 8.  Ceramide and Related Molecules in Viral Infections.

Authors:  Nadine Beckmann; Katrin Anne Becker
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.